T. Rôle-de and .. Exprimé-par-les-cellules-tumorales-et-les-cellules-immunitaires-de-l-'hôte??, ???????????????????.57 4.1.2. Etude de l'effet anti-tumoral d'un antagoniste de TLR7, IRS661, p.59

T. Impact-de and .. Dans-la-survenue-des-métastases, 60 4.2.1. Détection in vivo des métastases, p.68

C. Et and D. , 70 5.1. Validation de l'effet pro-tumoral de TLR7 dans un modèle murin, p.73

. Cherfils-vicini, Afin d'étudier l'implication de ce récepteur dans le développement des métastases dans notre modèle, j'ai cultivé les cellules LLC-luc pendant 6 ou 12 heures avec différents agonistes de TLR7, 2010.

K. Adachi and K. Tamada, Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy, Cancer Science, vol.151, issue.8, 2015.
DOI : 10.1111/cas.12695

S. Akira and K. Takeda, Toll-like receptor signalling, Nature Reviews Immunology, vol.303, issue.7, pp.499-511, 2004.
DOI : 10.1038/nri1391

F. Balkwill, C. , and L. M. , Cancer: An inflammatory link, Nature, vol.2, issue.7007, pp.405-406, 2004.
DOI : 10.1016/S1470-2045(03)01196-3

F. Balkwill and A. Mantovani, Inflammation and cancer: back to Virchow?, The Lancet, vol.357, issue.9255, pp.539-545, 2001.
DOI : 10.1016/S0140-6736(00)04046-0

F. J. Barrat, T. Meeker, J. Gregorio, J. H. Chan, S. Uematsu et al., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus, The Journal of Experimental Medicine, vol.32, issue.8, pp.1131-1139, 2005.
DOI : 10.4049/jimmunol.171.6.3296

S. Chatterjee, L. Crozet, D. Damotte, K. Iribarren, C. Schramm et al., TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small Cell Lung Cancer, Cancer Research, vol.74, issue.18, pp.5008-5018, 2014.
DOI : 10.1158/0008-5472.CAN-13-2698

J. Cherfils-vicini, S. Platonova, M. Gillard, L. Laurans, P. Validire et al., Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance, Journal of Clinical Investigation, vol.120, issue.4, pp.1285-1297, 2010.
DOI : 10.1172/JCI36551DS1

S. C. Chow, S. D. Gowing, J. J. Cools-lartigue, C. B. Chen, J. Berube et al., toll-like receptor 4 activation and mitogen-activated protein kinase phosphorylation, International Journal of Cancer, vol.4, issue.6, pp.1341-1350, 2015.
DOI : 10.1002/ijc.29111

P. Clive and M. J. Page, Pharmacologie Intégrée, 1999.

L. M. Coussens and Z. Werb, Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002.
DOI : 10.1006/cyto.1996.0074

C. J. Creighton, D. L. Gibbons, and J. M. Kurie, The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspective, Cancer Management and Research, vol.5, pp.187-195, 2013.
DOI : 10.2147/CMAR.S35171

M. Dajon, K. Iribarren, and I. Cremer, Dual roles of TLR7 in the lung cancer microenvironment, OncoImmunology, vol.4, issue.3, 2015.
DOI : 10.1158/0008-5472.CAN-05-3948

M. Dieu-nosjean, M. Antoine, C. Danel, D. Heudes, M. Wislez et al., Long-Term Survival for Patients With Non???Small-Cell Lung Cancer With Intratumoral Lymphoid Structures, Journal of Clinical Oncology, vol.26, issue.27, pp.4410-4417, 2008.
DOI : 10.1200/JCO.2007.15.0284

B. Drobits, M. Holcmann, N. Amberg, M. Swiecki, R. Grundtner et al., Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells, Journal of Clinical Investigation, vol.122, issue.2, pp.575-585, 2012.
DOI : 10.1172/JCI61034DS1

G. P. Dunn, L. J. Old, and R. D. Schreiber, The Three Es of Cancer Immunoediting, Annual Review of Immunology, vol.22, issue.1, pp.329-360, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104803

M. Dupage, A. L. Dooley, and T. Jacks, Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase, Nature Protocols, vol.180, issue.8, pp.1064-1072, 2009.
DOI : 10.1038/5007

M. Dupage, C. Mazumdar, L. M. Schmidt, A. F. Cheung, and T. Jacks, Expression of tumour-specific antigens underlies cancer immunoediting, Nature, vol.4, issue.7385, pp.405-409, 2012.
DOI : 10.1038/nature10803

M. Fabbri, TLRs as miRNA Receptors, Cancer Research, vol.72, issue.24, pp.6333-6337, 2012.
DOI : 10.1158/0008-5472.CAN-12-3229

M. Fabbri, A. Paone, F. Calore, R. Galli, E. Gaudio et al., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response, Proceedings of the National Academy of Sciences, vol.109, issue.31, pp.2110-2116, 2012.
DOI : 10.1073/pnas.1209414109
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412003

Y. Feng, H. Chen, J. Cai, L. Zou, D. Yan et al., Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via Toll-like receptor 7 signaling, J. Biol, 2015.
DOI : 10.1074/jbc.m115.661835
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646323

M. R. Galdiero, E. Bonavita, I. Barajon, C. Garlanda, A. Mantovani et al., Tumor associated macrophages and neutrophils in cancer, Immunobiology, vol.218, issue.11, pp.1402-1410, 2013.
DOI : 10.1016/j.imbio.2013.06.003

L. J. Gay and B. Felding-habermann, Contribution of platelets to tumour metastasis, Nature Reviews Cancer, vol.33, issue.2, pp.123-134, 2011.
DOI : 10.1038/nrc3004

A. Gazdar, L. Robinson, D. Oliver, C. Xing, W. D. Travis et al., Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations, Journal of Thoracic Oncology, vol.9, issue.4, pp.456-463, 2014.
DOI : 10.1097/JTO.0000000000000130
URL : http://doi.org/10.1097/jto.0000000000000130

C. Germain, S. Gnjatic, F. Tamzalit, S. Knockaert, R. Remark et al., Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer, American Journal of Respiratory and Critical Care Medicine, vol.189, issue.7, pp.832-844, 2014.
DOI : 10.1164/rccm.201309-1611OC

M. Gillard-bocquet, C. Caer, N. Cagnard, L. Crozet, M. Perez et al., Lung Tumor Microenvironment Induces Specific Gene Expression Signature in Intratumoral NK Cells, Frontiers in Immunology, vol.4, 2013.
DOI : 10.3389/fimmu.2013.00019
URL : http://doi.org/10.3389/fimmu.2013.00019

J. Goc, C. Germain, T. K. Vo-bourgais, A. Lupo, C. Klein et al., Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells, Cancer Research, vol.74, issue.3, pp.705-715, 2014.
DOI : 10.1158/0008-5472.CAN-13-1342

P. Goldstraw, J. Crowley, K. Chansky, D. J. Giroux, P. A. Groome et al., International Association for the Study of Lung Cancer International Staging Committee The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours, J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer, vol.2, pp.706-714, 2007.

Y. Goto, T. Arigami, M. Kitago, S. L. Nguyen, N. Narita et al., Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors, Molecular Cancer Therapeutics, vol.7, issue.11, pp.3642-3653, 2008.
DOI : 10.1158/1535-7163.MCT-08-0582

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

E. L. Hopewell, W. Zhao, W. J. Fulp, C. C. Bronk, A. S. Lopez et al., Lung tumor NF-??B signaling promotes T cell???mediated immune surveillance, Journal of Clinical Investigation, vol.123, issue.6, pp.2509-2522, 2013.
DOI : 10.1172/JCI67250DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668836

A. Huang, B. Zhang, B. Wang, F. Zhang, K. Fan et al., Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients, Cancer Immunology, Immunotherapy, vol.119, issue.24, pp.1439-1451, 2013.
DOI : 10.1007/s00262-013-1450-6

B. Huang, J. Zhao, J. C. Unkeless, Z. H. Feng, and H. Xiong, TLR signaling by tumor and immune cells: a double-edged sword, Oncogene, vol.170, issue.2, pp.218-224, 2008.
DOI : 10.1158/1055-9965.EPI-05-0874

S. Ioannou and M. Voulgarelis, Toll-Like Receptors, Tissue Injury, and Tumourigenesis, Mediators of Inflammation, vol.32, issue.11, 2010.
DOI : 10.2165/00128071-200506030-00006
URL : http://doi.org/10.1155/2010/581837

C. N. Jenne, Platelets: crossroads of immunity and hemostasis, Blood, vol.124, issue.5, pp.671-672, 2014.
DOI : 10.1182/blood-2014-05-572875

J. A. Joyce and J. W. Pollard, Microenvironmental regulation of metastasis, Nature Reviews Cancer, vol.19, issue.4, pp.239-252, 2009.
DOI : 10.1038/nrc2618

A. A. Keskinov and M. R. Shurin, Myeloid regulatory cells in tumor spreading and metastasis, Immunobiology, vol.220, issue.2, pp.236-242, 2015.
DOI : 10.1016/j.imbio.2014.07.017

T. Kitamura, B. Qian, and J. W. Pollard, Immune cell promotion of metastasis, Nature Reviews Immunology, vol.510, issue.2, pp.73-86, 2015.
DOI : 10.1189/jlb.1212631

G. Landskron, M. De-la-fuente, P. Thuwajit, C. Thuwajit, and M. A. Hermoso, Chronic Inflammation and Cytokines in the Tumor Microenvironment, Journal of Immunology Research, vol.145, issue.6, p.149185, 2014.
DOI : 10.1097/MOG.0b013e32834405c3

E. Latz, A. Verma, A. Visintin, M. Gong, C. M. Sirois et al., Ligand-induced conformational changes allosterically activate Toll-like receptor 9, Nature Immunology, vol.177, issue.7, pp.772-779, 2007.
DOI : 10.1038/ni1479

M. F. Leber and T. Efferth, Molecular principles of cancer invasion and metastasis (review), 2009.

K. Liu, L. Ding, and H. Wu, Bevacizumab in combination with anticancer drugs for previously treated advanced non-small cell lung cancer, Tumor Biology, vol.3, issue.Suppl 3, 2015.
DOI : 10.1007/s13277-014-2962-1

K. B. Long and G. L. Beatty, Harnessing the antitumor potential of macrophages for cancer immunotherapy, OncoImmunology, vol.60, issue.12, 2013.
DOI : 10.1158/0008-5472.CAN-12-3981

K. A. Luddy, M. Robertson-tessi, N. K. Tafreshi, H. Soliman, M. et al., The role of tolllike receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition, Front. Immunol, vol.5, p.429, 2014.

D. Marvel and D. I. Gabrilovich, Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected, Journal of Clinical Investigation, vol.125, issue.9, pp.3356-3364, 2015.
DOI : 10.1172/JCI80005

H. Matsushima, N. Yamada, H. Matsue, and S. Shimada, TLR3-, TLR7-, and TLR9-Mediated Production of Proinflammatory Cytokines and Chemokines from Murine Connective Tissue Type Skin-Derived Mast Cells but Not from Bone Marrow-Derived Mast Cells, The Journal of Immunology, vol.173, issue.1, pp.531-541, 2004.
DOI : 10.4049/jimmunol.173.1.531

S. Miretti, I. Roato, R. Taulli, C. Ponzetto, M. Cilli et al., A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging, PLoS ONE, vol.21, issue.3, 1828.
DOI : 10.1371/journal.pone.0001828.t001

J. R. Molina, P. Yang, S. D. Cassivi, S. E. Schild, and A. A. Adjei, Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship, Mayo Clinic Proceedings, vol.83, issue.5, pp.584-594, 2008.
DOI : 10.1016/S0025-6196(11)60735-0

C. Moreno and A. Sánchez-ibarrola, [Toll type receptors: molecular bases of the relationship between innate and adaptation responses of the immune system], Rev. Med. Univ. Navarra, vol.47, pp.29-33, 2003.

E. S. Nakamura, K. Koizumi, M. Kobayashi, Y. Saitoh, Y. Arita et al., RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4, Clinical & Experimental Metastasis, vol.84, issue.1, 2006.
DOI : 10.1007/s10585-006-9006-1

A. Ochi, C. S. Graffeo, C. P. Zambirinis, A. Rehman, M. Hackman et al., Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans, Journal of Clinical Investigation, vol.122, issue.11, pp.4118-4129, 2012.
DOI : 10.1172/JCI63606DS1

I. S. Okon, K. A. Coughlan, M. Zhang, Q. Wang, and M. Zou, Gefitinib-mediated ROS instigates mitochondrial dysfunction and drug resistance in lung cancer cells, J. Biol. Chem, 2015.

P. B. Olkhanud, D. Baatar, M. Bodogai, F. Hakim, R. Gress et al., Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells, Cancer Research, vol.69, issue.14, pp.5996-6004, 2009.
DOI : 10.1158/0008-5472.CAN-08-4619

J. Pradere, D. H. Dapito, and R. F. Schwabe, The Yin and Yang of Toll-like receptors in cancer, Oncogene, vol.123, issue.27, pp.3485-3495, 2014.
DOI : 10.1161/CIRCINTERVENTIONS.111.967596

S. Rakoff-nahoum and R. Medzhitov, Toll-like receptors and cancer, Nature Reviews Cancer, vol.5, issue.1, pp.57-63, 2009.
DOI : 10.1182/blood-2007-05-088682

R. Remark, M. Alifano, I. Cremer, A. Lupo, M. Dieu-nosjean et al., Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin, Clinical Cancer Research, vol.19, issue.15, 2013.
DOI : 10.1158/1078-0432.CCR-12-3847

D. Sanctis, F. Solito, S. Ugel, S. Molon, B. Bronte et al., MDSCs in cancer: Conceiving new prognostic and therapeutic targets, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1865, issue.1, 2015.
DOI : 10.1016/j.bbcan.2015.08.001

P. J. Sarvaiya, D. Guo, I. Ulasov, P. Gabikian, and M. S. Lesniak, Chemokines in tumor progression and metastasis, Oncotarget, vol.4, issue.12, pp.2171-2185, 2013.
DOI : 10.18632/oncotarget.1426

Y. Sato, Y. Goto, N. Narita, and D. S. Hoon, Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment, Cancer Microenvironment, vol.264, issue.Suppl 3, pp.205-214, 2009.
DOI : 10.1007/s12307-009-0022-y

M. C. Schmid and J. A. Varner, Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation, Journal of Oncology, vol.87, issue.8, 2010.
DOI : 10.1038/nature04483

S. Singh, A. Sadanandam, and R. K. Singh, Chemokines in tumor angiogenesis and metastasis, Cancer and Metastasis Reviews, vol.9, issue.4, pp.453-467, 2007.
DOI : 10.1007/s10555-007-9068-9

M. K. Srivastava, L. Zhu, M. Harris-white, U. Kar, M. Huang et al., Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer, PLoS ONE, vol.163, issue.7, p.40677, 2012.
DOI : 10.1371/journal.pone.0040677.t001

J. P. Thiery, H. Acloque, R. Y. Huang, and M. A. Nieto, Epithelial-Mesenchymal Transitions in Development and Disease, Cell, vol.139, issue.5, pp.871-890, 2009.
DOI : 10.1016/j.cell.2009.11.007

T. Tsujikawa, T. Yaguchi, G. Ohmura, S. Ohta, A. Kobayashi et al., CCR4/CCL22 in head and neck squamous cell carcinoma, International Journal of Cancer, vol.118, issue.12, pp.2755-2766, 2013.
DOI : 10.1002/ijc.27966

Y. Yamamoto and R. B. Gaynor, Therapeutic potential of inhibition of the NF-??B pathway in the treatment of inflammation and cancer, Journal of Clinical Investigation, vol.107, issue.2, pp.135-142, 2001.
DOI : 10.1172/JCI11914

H. Yang, B. Wang, T. Wang, L. Xu, C. He et al., Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis, PLoS ONE, vol.14, issue.10, 2014.
DOI : 10.1371/journal.pone.0109980.s002

L. Yu, L. Wang, C. , and S. , Endogenous toll-like receptor ligands and their biological significance, Journal of Cellular and Molecular Medicine, vol.213, issue.11, pp.2592-2603, 2010.
DOI : 10.1111/j.1582-4934.2010.01127.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373479

L. Yu, L. Yan, W. Yang, F. Wu, Y. Ling et al., Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein, Nature Communications, vol.40, p.5256, 2014.
DOI : 10.1371/journal.pone.0026125
URL : http://doi.org/10.1038/ncomms6256

S. Zhao, Y. Zhang, Q. Zhang, F. Wang, and D. Zhang, Toll-like receptors and prostate cancer. Tumor Immun, p.352, 2014.

M. Zimmerman, X. Hu, and K. Liu, Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model, Journal of Visualized Experiments, issue.45, 2010.
DOI : 10.3791/2077
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159593

I. La-ligue-contre-le-cancer, Les cancer du Poumon Récupéré sur http Lo que necesita saber sobre el cancer de pulmon Récupéré sur http://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/wyntk-pulmon Récupéré sur http Récupéré sur http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx NanoString® Technologies, I. (s.d.). GEN2 Prep Station User Manual. Récupéré sur http Formation des Métastases, National Cancer Institute.pdf Oncoprof. UE Cancérologie EPHE, 2009.